Delegated prescriptive authority is documented through four items kept on file at all times: a signed collaborating physician agreement naming the specific drug classes delegated, written standing orders or protocols covering each medication category, a scope-of-practice addendum stating supervision ratios and practice locations, and a chart review log showing the physician actually reviewed the required percentage of charts on schedule. Missing any one of these four is the most common finding when state boards audit aesthetic practices in 2026, and it's usually the chart review log that's thin or missing entirely.
- Delegated prescriptive authority documentation requires 4 items: the agreement, standing orders, a scope addendum, and a chart review log.
- Boards cite incomplete chart review logs more than any other gap in 2026 aesthetic practice audits.
- Standing orders must name specific drugs and dosing ranges — a generic protocol doesn’t satisfy delegation requirements.
- Supervision ratios and review frequency vary by state, so the same paperwork won’t pass in every jurisdiction.
Why this matters
A collaborating physician's signature on an agreement is not proof of active delegation. Boards want to see the physician's fingerprints on the actual clinical decisions being delegated — which drugs, at what doses, reviewed how often, and by whom.
When a nurse practitioner or aesthetic injector prescribes or administers a controlled substance analog, a peptide, or a prescription-only injectable under someone else's license, the paper trail is what separates lawful delegation from unlicensed practice. In 2026, several states have tightened chart co-signature timelines specifically because that trail was missing in enforcement cases.
How to document delegated prescriptive authority under a collaborating physician
Follow these steps in order. Each one produces a document a board investigator or malpractice carrier will ask for by name.
- Name the delegated drug classes in the agreement itself. "Supervision of aesthetic services" is not delegation language. The agreement needs a specific list — botulinum toxin, dermal fillers, tirzepatide or semaglutide, hormone pellets, whatever applies — with dosing authority spelled out or referenced to an attached protocol.
- Attach written standing orders for each drug class. Standing orders translate the delegation into a clinical instruction: indications, contraindications, dosing range, and what triggers a call to the physician. A collaborating physician agreement without standing orders attached is incomplete on its face.
- Log chart reviews on a set schedule, not on request. Most states require review of a percentage of charts within a defined window — weekly, monthly, or quarterly depending on jurisdiction. The log needs a date, a physician signature, and the specific charts reviewed.
- Keep a scope-of-practice addendum current. This document ties supervision ratios and physical or telehealth practice locations to the agreement. When a practice adds a location or a new provider, the addendum updates before that provider sees a patient.
- File the delegation packet where an auditor can find it in minutes. Boards note response time. A practice that produces the full packet in five minutes reads very differently than one still assembling it a week later.
Standing orders: the piece most practices get wrong
Standing orders fail audits for one of two reasons: they're too generic to count as delegation, or they're outdated against the drugs the practice actually offers now. A standing order written in 2023 for Botox and filler doesn't cover a tirzepatide program added in 2026. Every time a service line changes, the standing orders for aesthetic nurse practitioners need a fresh signature, not just a verbal go-ahead.
Chart review logs: the audit trail that proves delegation is active
A signed agreement proves delegation exists on paper. A chart review log proves it's being exercised. The log should show what was reviewed, when, and whether the physician flagged anything for correction — a blank "reviewed, no issues" line every time looks worse to an auditor than a log with occasional real notes. Practices that centralize this into one recurring workflow tend to pass inspection faster; see how to document chart reviews for medical director compliance for the format boards expect.
Why documentation requirements vary
- State delegation statutes differ on review frequency — some require weekly chart sampling, others monthly or quarterly.
- Supervision ratios cap how many providers one physician can delegate to, which changes how much documentation volume a single collaborating physician generates.
- Drug class matters — controlled substances and compounded medications typically carry stricter co-signature and review timelines than topical or injectable aesthetics.
- Telehealth delegation adds a layer — multi-state practices need documentation that satisfies both the prescriber's home state and the patient's state.
- Practice type shifts the paperwork — a solo NP-owned clinic documents differently than a multi-location medspa group with several delegated providers under one collaborating physician.
Getting the supervision ratio rules for collaborating physicians wrong is one of the fastest ways to invalidate an otherwise solid documentation packet, because a physician delegating to more providers than the state allows makes every downstream chart review technically noncompliant.
Related questions
Is a verbal delegation of prescriptive authority ever enough?
No — verbal delegation alone does not satisfy documentation requirements in any state that regulates collaborating physician relationships. The agreement, standing orders, and review log all need to exist in writing before a provider prescribes under delegated authority, not after.
How does delegation documentation change for telehealth weight-loss prescribing?
Telehealth weight-loss prescribing under delegated authority needs documentation covering both the prescriber's state and the patient's state, plus a protocol specific to the medication being prescribed. This is where compounded medication programs draw the most scrutiny in 2026, since verification of the source and legitimacy of the compound sits alongside the delegation paperwork — practices sourcing compounded GLP-1 medications should be comfortable with verifying legitimate compounded prescriptions before that protocol goes into a chart.
What should a practice do if a collaborating physician relationship ends mid-delegation?
Stop prescribing under that delegation immediately and notify the state board per the transition rules that apply to the license type. Every open standing order tied to that physician needs a signature from the incoming collaborating physician before any provider resumes prescribing under it — see the process for how to switch collaborating physicians without disruption for the handoff sequence.
FAQ
What is delegated prescriptive authority in a collaborating physician relationship?
Delegated prescriptive authority is a physician’s written permission for a nurse practitioner, PA, or other licensed provider to prescribe or administer specific medications under standing orders. It’s documented through the collaborating physician agreement, drug-specific standing orders, and a scope-of-practice addendum, not through a verbal understanding.
How often must a collaborating physician review charts under delegated authority?
Review frequency is set by state statute and ranges from weekly to quarterly depending on jurisdiction. The chart review log needs to show the actual date, charts reviewed, and physician signature for each cycle, not just a blanket monthly note.
Do standing orders count as documentation of delegated prescriptive authority?
Yes, standing orders are one of the four required pieces, but they only count if they name specific drug classes and dosing ranges. A generic reference to ‘aesthetic services’ in an agreement does not satisfy delegation documentation requirements.
What happens if delegation documentation is incomplete during an audit?
Incomplete delegation documentation is one of the most common findings in 2026 board audits of aesthetic practices, and it can trigger a corrective action plan or a hold on prescribing privileges until the gap is fixed. A missing chart review log is the single most frequent citation.
Can a nurse practitioner prescribe under delegated authority without a written protocol?
No, prescribing without a written protocol on file is treated as practicing outside delegated scope in nearly every state that regulates collaborating physician relationships. The protocol has to be signed and dated before the first prescription under that delegation.
How is delegated prescriptive authority different from independent practice authority?
Delegated prescriptive authority requires an active collaborating physician relationship with documentation on file, while independent practice authority allows a provider to prescribe without physician oversight in states that grant it. The two require entirely different paperwork, and a provider moving between states needs to confirm which model applies before prescribing.
One last thing
The documentation piece practices skip most often isn't the agreement or the standing orders — it's updating the scope-of-practice addendum when a new service line launches. A practice that added tirzepatide prescribing in 2026 without updating the addendum has a technically valid collaborating physician agreement covering services it no longer only offers, which is exactly the gap an auditor is trained to find first.
Get delegation paperwork audit-ready
Review your standing orders, agreement, and chart logs before a board asks for them.
Related guides
- How to structure a collaborating physician agreement
- How to draft standing orders for aesthetic nurse practitioners
- How to document chart reviews for medical director compliance
- How to meet supervision ratio rules for collaborating physicians
- How to switch collaborating physicians without disruption
